BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 7989932)

  • 1. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia.
    Sebban C; Lepage E; Vernant JP; Gluckman E; Attal M; Reiffers J; Sutton L; Racadot E; Michallet M; Maraninchi D
    J Clin Oncol; 1994 Dec; 12(12):2580-7. PubMed ID: 7989932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia.
    Fière D; Lepage E; Sebban C; Boucheix C; Gisselbrecht C; Vernant JP; Varet B; Broustet A; Cahn JY; Rigal-Huguet F
    J Clin Oncol; 1993 Oct; 11(10):1990-2001. PubMed ID: 8410124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission.
    Vey N; Blaise D; Stoppa AM; Bouabdallah R; Lafage M; Sainty D; Cowen D; Viens P; Lepeu G; Blanc AP
    Bone Marrow Transplant; 1994 Sep; 14(3):383-8. PubMed ID: 7994259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission.
    De Witte T; Awwad B; Boezeman J; Schattenberg A; Muus P; Raemaekers J; Preijers F; Strijckmans P; Haanen C
    Bone Marrow Transplant; 1994 Nov; 14(5):767-74. PubMed ID: 7889010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial.
    Hunault M; Harousseau JL; Delain M; Truchan-Graczyk M; Cahn JY; Witz F; Lamy T; Pignon B; Jouet JP; Garidi R; Caillot D; Berthou C; Guyotat D; Sadoun A; Sotto JJ; Lioure B; Casassus P; Solal-Celigny P; Stalnikiewicz L; Audhuy B; Blanchet O; Baranger L; Béné MC; Ifrah N;
    Blood; 2004 Nov; 104(10):3028-37. PubMed ID: 15256423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group.
    Sweetenham JW; Santini G; Qian W; Guelfi M; Schmitz N; Simnett S; Nagler A; Holte H; Kvaloy S; Bruzzi P; Goldstone AH
    J Clin Oncol; 2001 Jun; 19(11):2927-36. PubMed ID: 11387366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
    Chim CS; Lie AK; Liang R; Au WY; Kwong YL
    Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study.
    Boulad F; Steinherz P; Reyes B; Heller G; Gillio AP; Small TN; Brochstein JA; Kernan NA; O'Reilly RJ
    J Clin Oncol; 1999 Jan; 17(1):197-207. PubMed ID: 10458234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.
    Woods WG; Kobrinsky N; Buckley J; Neudorf S; Sanders J; Miller L; Barnard D; Benjamin D; DeSwarte J; Kalousek D
    J Clin Oncol; 1993 Aug; 11(8):1448-57. PubMed ID: 8336184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
    Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
    Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Ribera JM; Grañena A; Rozman C; Urbano-Ispizua A; Bladé J; Carreras E; Cervantes F; Marín P; Sierra J; Nomdedeu B
    Sangre (Barc); 1990 Feb; 35(1):26-32. PubMed ID: 2333581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial.
    Thomas X; Boiron JM; Huguet F; Dombret H; Bradstock K; Vey N; Kovacsovics T; Delannoy A; Fegueux N; Fenaux P; Stamatoullas A; Vernant JP; Tournilhac O; Buzyn A; Reman O; Charrin C; Boucheix C; Gabert J; Lhéritier V; Fiere D
    J Clin Oncol; 2004 Oct; 22(20):4075-86. PubMed ID: 15353542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission.
    Woods WG; Neudorf S; Gold S; Sanders J; Buckley JD; Barnard DR; Dusenbery K; DeSwarte J; Arthur DC; Lange BJ; Kobrinsky NL;
    Blood; 2001 Jan; 97(1):56-62. PubMed ID: 11133742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
    N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of long-term survival between bone marrow transplantation and maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission].
    Suzuki N; Koike T; Furukawa T; Niwano H; Maruyama S; Narita M; Takizawa J; Sato N; Hashimoto S; Nikkuni K; Toba K; Kishi K; Takahashi M; Aizawa Y; Shibata A
    Rinsho Ketsueki; 1997 Feb; 38(2):95-9. PubMed ID: 9059062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
    Balduzzi A; Valsecchi MG; Uderzo C; De Lorenzo P; Klingebiel T; Peters C; Stary J; Felice MS; Magyarosy E; Conter V; Reiter A; Messina C; Gadner H; Schrappe M
    Lancet; 2005 Aug 20-26; 366(9486):635-42. PubMed ID: 16112299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).
    Harousseau JL; Cahn JY; Pignon B; Witz F; Milpied N; Delain M; Lioure B; Lamy T; Desablens B; Guilhot F; Caillot D; Abgrall JF; Francois S; Briere J; Guyotat D; Casassus P; Audhuy B; Tellier Z; Hurteloup P; Herve P
    Blood; 1997 Oct; 90(8):2978-86. PubMed ID: 9376578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group.
    Attal M; Blaise D; Marit G; Payen C; Michallet M; Vernant JP; Sauvage C; Troussard X; Nedellec G; Pico J
    Blood; 1995 Aug; 86(4):1619-28. PubMed ID: 7632972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
    Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
    Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.